Topic - Glaxosmithkline Plc

Related Stories

FILE - This April 20, 2009 file photo, shows the British pharmaceuticals firm GlaxoSmithKline in London. Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds ($12.7 billion). British-based Glaxo will own 68 percent of the joint venture, while U.S.-based Pfizer will own the remaining 32 percent stake. (AP Photo/Sang Tan, File)

Glaxo, Pfizer to merge consumer health care divisions

By DANICA KIRKA and LINDA A. JOHNSON - Associated Press

Correction: FDA-Shingles Vaccine story

By The Associated Press - Associated Press

FILE - The Oct. 19, 2012 file photo shows a Novartis employee in a laboratory of Novartis in Prangins near Nyon, Switzerland. Swiss pharmaceutical giant Novartis AG announced a series of multibillion-dollar deals Tuesday, April 22, 2014 with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally. (AP Photo/Keystone, Yannick Bailly)

Novartis reshapes business with GSK, Lilly deals

By JOHN HEILPRIN - Associated Press

FDA approves injectable diabetes drug from Glaxo

Associated Press

Glaxo donates NC Wyeth painting to Philly museum

By JOANN LOVIGLIO - Associated Press

GlaxoSmithKline to pay $3B for health fraud

By LINDA A. JOHNSON - Associated Press

FDA panel backs first new lupus drug in 50 years

By MATTHEW PERRONE - Associated Press

Spiriva as good as Serevent in asthma study

By ALICIA CHANG - Associated Press

Vaccine sales up 16 pct in 2009, still growing

By LINDA A. JOHNSON - Associated Press

FDA warns of brain problem with Glaxo seizure drug

By ASSOCIATED PRESS - Associated Press